1. Enrollment of Older Adults in Clinical Trials Evaluating Patients with Hematologic Malignancies – the Food and Drug Administration (FDA);Kanapuru,2017
2. Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, et al. (eds). SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2016/, based on November 2018 SEER data submission, posted to the SEER web site, April 2019.
3. Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma;Facon;Blood.,2018
4. Daratumumab plus bortezomib, melphalan, and Prednisone for untreated myeloma;Mateos;N. Engl. J. Med.,2018
5. Daratumumab plus lenalidomide and dexamethasone for untreated myeloma;Facon;N. Engl. J. Med.,2019